Skip to content
Open access

Integrated PET/MRI for the evaluation of gray matter atrophy and metabolic changes in idiopathic Parkinson’s disease

Jul 2026 · Frontiers in Aging Neuroscience · Vol 18 · 0 citations · 67 references
Medicine

TL;DR

Widespread RFS predominates during early stages, whereas structural atrophy gradually becomes the dominant imaging feature as the disease advances, underscoring the potential of multimodal imaging biomarkers for the early diagnosis of IPD.

Abstract

Background The underlying mechanisms linking structural and metabolic alterations of idiopathic Parkinson’s disease (IPD) remain poorly understood. Utilizing integrated PET/MR for its precise spatial correlation, this study investigated the temporal relationship between gray matter (GM) atrophy and reduced FDG SUVR (RFS) across IPD stages to provide insights for early diagnosis. Methods This prospective study recruited 90 IPD patients stratified by Hoehn-Yahr (H-Y) stage into mild, moderate, and severe groups, alongside 30 age-matched healthy controls (HC). All participants underwent integrated 18F-FDG PET/MR imaging. SPM was used to extract the GM volume (VGM) and standardized uptake value ratio for each brain region. Group differences were analyzed with one-way ANOVA and Bonferroni tests. Spearman correlation analysis was utilized to evaluate the associations of both VGM and metabolic changes with H-Y staging. Individual Z-scores for VGM and metabolic alterations were calculated, and their relationship was examined using Spearman/Pearson correlation, followed by paired t-tests to compare their differences. Result With disease progression, GM atrophy and RFS in IPD patients gradually extend from focal to widespread patterns. A characteristic pattern of cerebral hypermetabolism was observed in IPD. H-Y stage demonstrated a significant inverse correlation with the extent of both brain GM atrophy (affecting 82 out of 90 regions) and RFS (affecting 20 regions). Conversely, it was positively correlated with hypermetabolism in regions including the sensorimotor cortex, amygdala, and globus pallidus. Moderate correlations between atrophy and RFS were confined to the left inferior parietal lobule (r = 0.619, p < 0.001) and superior temporal gyrus of the temporal pole (r = 0.612, p < 0.001) only in severe group. In early stages, the number of regions where RFS predominated over atrophy (57 regions) substantially exceeded those where atrophy was more severe (1 region). In late stages, the number of regions with more pronounced atrophy than RFS (25 regions) surpassed that of regions where RFS was dominant (12 regions). Conclusion Widespread RFS predominates during early stages, whereas structural atrophy gradually becomes the dominant imaging feature as the disease advances. These alterations are significantly correlated with disease severity, underscoring the potential of multimodal imaging biomarkers for the early diagnosis of IPD and monitor its progression.

Read PDF

Similar papers

Jul 2026

[18F]FDG PET outperforms MRI for detecting early tau-related neurodegeneration.

Hypometabolism is a sensitive and early marker of AD-related neurodegeneration, preceding MRI-detectable GM atrophy and more closely reflecting underlying tau pathology across disease stages.

Orfeas Vourkas, Linda Zhang, Andrés Jiménez-Pérez et al. · 0 citations
Jul 2026

MRI-free amyloid PET quantification using a deep learning model and white matter reference

Deep learning–based amyloid PET segmentation enables accurate MRI-free quantification of gray and white matter SUVRs and simplifies clinical workflow while maintaining diagnostic performance comparable to MRI-based methods for AD diagnosis.

Seung-Ho Shin, Yong-Jun Mo, Hee Sung Hwang et al. · 0 citations
Open access Aug 2026

Magnetic Resonance Imaging-Based Cortical and Subcortical Volumetric Changes in Alzheimer’s Disease: Association with Clinical Severity

Background/Objectives: This study evaluated automated magnetic resonance imaging (MRI) volumetry for characterizing structural brain changes in Alzheimer’s disease (AD), mild cognitive impairment (MCI), and cognitively healthy controls (HC), and examined its association with cognitive performance. Methods: This retrosp...

A. Alagoz, Serap Ozturk, S. D. Bunul et al. · 0 citations
Open access Jul 2026

Diffusion MRI Is More Sensitive Than Tau PET and Regional Volume Loss in Corticobasal Syndrome

Background: Corticobasal syndrome (CBS) is a neurodegenerative syndrome that often results from a 4-repeat tauopathy. Abnormalities on tau PET, structural MRI, and diffusion MRI (dMRI) have been observed in CBS, although no prior work has systematically compared the relative sensitivity of these modalities. In addition...

Yuqi Tian, Ryota Satoh, Val J. Lowe et al. · 0 citations
Open access Sep 2026

Identification of MRI-Derived Structural Biomarkers in Female Alzheimer’s Disease Subjects Using CAT12 and Mimics: Effects of Voxel Geometry on Biomarker Estimation

Alzheimer’s disease (AD) is the leading cause of dementia and disproportionately affects women, who experience a higher lifetime risk and more rapid structural brain changes than men. Reliable imaging biomarkers are essential for detecting these changes, although their estimation may be influenced by voxel geometry, im...

Devang Nilesh Thakur, Tarun Goswami · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.